Pear Therapeutics logo

Pear Therapeutics Funding & Investors

Boston, MA

Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.

peartherapeutics.com

Total Amount Raised: $409,000,000

Pear Therapeutics Funding Rounds

  • IPO

    Unknown

  • Post Ipo Equity

    $125,000,000

    Post Ipo Equity Investors

    Shanda
    5am Ventures
    Forth Management
    SoftBank Vision Fund
    Blue Water Life Science Fund
    QUAD Investment Management
    Neuberger Berman
    Temasek Holdings (Private)
    Palantir Capital
    Pilot House Ventures
    Jazz Venture Partners
    Arboretum Ventures
    dRx Capital
    Sarissa Capital Management
    The Eleven Fund
    Pritzker Vlock Family Office
    Trustbridge Partners
  • Series D

    $20,000,000

  • Series D

    $80,000,000

    Series D Investors

    SoftBank Vision Fund
    EDBI
    Temasek Holdings (Private)
    QUAD Investment Management
    5am Ventures
    Arboretum Ventures
    Jazz Venture Partners
    Forth Management
    Crimsonox Capital
    Novartis
    Shanda
    Pilot House Ventures
    Sarissa Capital Management
  • Debt Financing

    $50,000,000

    Debt Financing Investors

    Perceptive Advisors
  • Series C

    $64,000,000

    Series C Investors

    Temasek Holdings (Private)
    EDBI
    Arboretum Ventures
    Jazz Venture Partners
    Novartis
    Blue Water Life Science Fund
    5am Ventures
    Bridge Builders Collaborative
    Trustbridge Partners
  • Series B

    $50,000,000

    Series B Investors

    Temasek Holdings (Private)
    Bridge Builders Collaborative
    Novartis
    5am Ventures
    EDBI
    Jazz Venture Partners
    Arboretum Ventures
    dRx Capital
  • Series A

    $20,000,000

    Series A Investors

    5am Ventures
    Arboretum Ventures
    Jazz Venture Partners
    Bridge Builders Collaborative
    Novartis
Funding info provided by Diffbot.